China’s drug regulator approved the country’s first coronavirus vaccine for general public use, a sign of confidence in the experimental shots that the nation plans to roll out within and beyond its borders.

China’s National Medical Products Administration gave its approval to a Covid-19 vaccine developed by state-owned China National Biotec Group Co., or CNBG, officials told reporters in Beijing Thursday.

With the approval, the vaccine -- which has been authorized for emergency use in China since mid-year along with other frontrunner shots -- will be made commercially available, meaning it can be administered to the general population. Regulators from the U.S. to Singapore have approved shots over the past month, among them vaccines developed by Pfizer Inc., Moderna Inc. and AstraZeneca Plc, but those have been largely for emergency use, a status China granted to its developers months ago.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook